---
pmid: '34354233'
title: ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection.
authors:
- Zhao F
- Kim W
- Gao H
- Liu C
- Zhang Y
- Chen Y
- Deng M
- Zhou Q
- Huang J
- Hu Q
- Chen SH
- Nowsheen S
- Kloeber JA
- Qin B
- Yin P
- Tu X
- Guo G
- Qin S
- Zhang C
- Gao M
- Luo K
- Liu Y
- Lou Z
- Yuan J
journal: Nat Cell Biol
year: '2021'
full_text_available: false
doi: 10.1038/s41556-021-00723-9
---

# ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end resection.
**Authors:** Zhao F, Kim W, Gao H, Liu C, Zhang Y, Chen Y, Deng M, Zhou Q, Huang J, Hu Q, Chen SH, Nowsheen S, Kloeber JA, Qin B, Yin P, Tu X, Guo G, Qin S, Zhang C, Gao M, Luo K, Liu Y, Lou Z, Yuan J
**Journal:** Nat Cell Biol (2021)
**DOI:** [10.1038/s41556-021-00723-9](https://doi.org/10.1038/s41556-021-00723-9)

## Abstract

1. Nat Cell Biol. 2021 Aug;23(8):894-904. doi: 10.1038/s41556-021-00723-9. Epub 
2021 Aug 5.

ASTE1 promotes shieldin-complex-mediated DNA repair by attenuating end 
resection.

Zhao F(#)(1), Kim W(#)(1), Gao H(2), Liu C(3), Zhang Y(1), Chen Y(4)(5), Deng 
M(1), Zhou Q(1), Huang J(1), Hu Q(6), Chen SH(7)(8), Nowsheen S(1)(9), Kloeber 
JA(1)(10), Qin B(1), Yin P(1), Tu X(1), Guo G(1), Qin S(2), Zhang C(1), Gao 
M(1), Luo K(1), Liu Y(3), Lou Z(11), Yuan J(12)(13).

Author information:
(1)Department of Oncology, Mayo Clinic, Rochester, MN, USA.
(2)Department of Molecular Pharmacology and Experimental Therapeutics, Mayo 
Clinic, Rochester, MN, USA.
(3)Department of Cancer Genetics and Epigenetics, Beckman Research Institute of 
City of Hope, Duarte, CA, USA.
(4)Key Laboratory of Arrhythmias of the Ministry of Education of China, Research 
Center for Translational Medicine, East Hospital, Tongji University School of 
Medicine, Shanghai, China.
(5)Department of Biochemistry and Molecular Biology, Tongji University School of 
Medicine, Shanghai, China.
(6)Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, 
USA.
(7)Institute of Biochemical Sciences, National Taiwan University, Taipei, 
Taiwan.
(8)Institute of Biological Chemistry, Academia Sinica, Taipei, Taiwan.
(9)Department of Dermatology, University of California San Diego, San Diego, CA, 
USA.
(10)Mayo Clinic Medical Scientist Training Program, Mayo Clinic Alix School of 
Medicine and Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, 
Rochester, MN, USA.
(11)Department of Oncology, Mayo Clinic, Rochester, MN, USA. 
Lou.zhenkun@mayo.edu.
(12)Key Laboratory of Arrhythmias of the Ministry of Education of China, 
Research Center for Translational Medicine, East Hospital, Tongji University 
School of Medicine, Shanghai, China. yuanjian229@hotmail.com.
(13)Department of Biochemistry and Molecular Biology, Tongji University School 
of Medicine, Shanghai, China. yuanjian229@hotmail.com.
(#)Contributed equally

Comment in
    Nat Cell Biol. 2021 Aug;23(8):818-819. doi: 10.1038/s41556-021-00731-9.

The shieldin complex functions as the downstream effector of 53BP1-RIF1 to 
promote DNA double-strand break end-joining by restricting end resection. The 
SHLD2 subunit binds to single-stranded DNA ends and blocks end resection through 
OB-fold domains. Besides blocking end resection, it is unclear how the shieldin 
complex processes SHLD2-bound single-stranded DNA and promotes non-homologous 
end-joining. Here, we identify a downstream effector of the shieldin complex, 
ASTE1, as a structure-specific DNA endonuclease that specifically cleaves 
single-stranded DNA and 3' overhang DNA. ASTE1 localizes to DNA damage sites in 
a shieldin-dependent manner. Loss of ASTE1 impairs non-homologous end-joining, 
leads to hyper-resection and causes defective immunoglobulin class switch 
recombination. ASTE1 deficiency also causes resistance to poly(ADP-ribose) 
polymerase inhibitors in BRCA1-deficient cells owing to restoration of 
homologous recombination. These findings suggest that ASTE1-mediated 3' 
single-stranded DNA end cleavage contributes to the control of DSB repair choice 
by 53BP1, RIF1 and shieldin.

Â© 2021. The Author(s), under exclusive licence to Springer Nature Limited.

DOI: 10.1038/s41556-021-00723-9
PMID: 34354233 [Indexed for MEDLINE]
